Vanguard USD Emerging Markets Government Bond UCITS ETF (PK) (VEMGF)

Agree I'm wondering if we get this class action law suit settled by court day ( this Thursday ) . It's a distraction . Would be good to get rid of it at a reasonable price rather than deal with discovery ( and the costs involved ) if it proceeds.
JMO
Kiwi

MONK you with me on RGNT ?

Here's a look at the move...

from my 19.33 alert

https://investorshub.advfn.com/uimage/uploads/2026/6/15/olsdiASTS.png

🤡Miro got you dummies again!🤡

FULTON BANK RELEASES 2025 CORPORATE SOCIAL RESPONSIBILITY REPORTJune 15, 2026 12:30 PM
PR Newswire (US) "Our Values in Action" highlights impact for communities and stakeholders class="legendSpanClass"LANCASTER, Pa., class=

$BURU Article June 12, 2026
Recharging submarines on the seabed wirelessly with a blue laser beam is what the agreement between the American NUBURU and the Italian SunCubes promises.https://en.clickpetroleoegas.com.br/recharging-submarines-on-the-seabed-wirelessly-with-a-blue-laser-beam-is-wh

ONCE THE BUYERS SHOW UP THIS WILL EXPLODE TO DIMES

“Clinical trials data,” to me, at that late stage, with the time that has passed, likely means an additional control arm, like that from, perhaps, SurvaxM 2b.

This can be due to the need for further documentation and/or clinical trials data, as well as other such considerations. — MHR

How much cash did they raise, can’t find number

65 years old and still Scamming

Reddit Tight_M : Tomkila, Q2 is indeed the next checkpoint. After Q1 delivered $8.6M net profit and $22.4M gross profit, the bar is set. Your expectations for Q2 are grounded in real trends:Revenue should continue climbing. Q1 was $104.9M. Q2 could hit $115-120M if the AI memory demand keeps its pac

"manufacturers" plural, interesting...

It's not interesting, it's British.

That's not 'plural' for them.

hit .12 today**. this week next week could break .02 or more imho.

RGNT kaboooooom

Volume crazy

$CVM The offering is set to close on June 16, 2026, with ThinkEquity acting as the sole placement agent.

Market Cap: $15.65 million, indicating a small-cap status in the biotechnology sector.
GF Score™: 21/100, suggesting significant challenges in financial strength and profita

DAVE:

https://investorshub.advfn.com/uimage/uploads/2026/6/15/gqzkxfolio1.JPG

The market is up, way up, as it should be. You would think NB would be flying too, especially considering the Traxys BINDING deal in imminent, the FS is imminent, and the EXIM terms are imminent.

Price prediction down the road or decade

$NCRA Nocera's announcement marked an important milestone in Nocera’s evolution.

By combining the IRMA AI Engine, strategic acquisition sourcing, capital markets expertise, and our previously announced $300M growth facility, we’re creating a platform designed to identify, fund, suppor

$NCRA Nocera's announcement marked an important milestone in Nocera’s evolution.

By combining the IRMA AI Engine, strategic acquisition sourcing, capital markets expertise, and our previously announced $300M growth facility, we’re creating a platform designed to identify, fund, suppor

Paid Fiction? So why do you pump then? The CEO doesn't even know his own balance sheet, let alone an anonymous iHub handle.

$BURU The recent 8-K filing marks another important step in the continued expansion of NUBURU’s integrated Defense & Security platform.

Through our binding Head of Terms with SunCubes, we are advancing the development of next-generation directed-energy and counter-UAS technologies whi

$BURU The recent 8-K filing marks another important step in the continued expansion of NUBURU’s integrated Defense & Security platform.

Through our binding Head of Terms with SunCubes, we are advancing the development of next-generation directed-energy and counter-UAS technologies whi

Again, it seems to me, NWBO would absolutely have an internal projected leuk clinic opening (fully licensed) date. They just don’t want to share it.

If they haven't decided to pause that project as well, and are simply waiting on the next Q to inform us lowly shareholders.